• Cohort study on the long-term effectiveness and safety of alemtuzumab in the treatment of multiplesclerosis

  Beà Navarro, Oriol (30-05-2023)

  Background: Alemtuzumab is a highly effective drug for the treatment of relapsing-remitting multiple sclerosis (MS). However, the occurrence of rare but serious adverse events after its commercialization has conditioned ...
• Assessment of effectiveness and vascular complications in large-caliber femoral venous access closure: A cohort study comparing perclose proglide TM SMC system versus manual compression and figure-of-eight suture

  Bosch Badó, Aina (30-05-2023)

  BACKGROUND The use of percutaneous interventional procedures in structural and congenital heart diseases has experienced a significant increase in recent years. As a result, there is a growing demand for large-caliber venous ...
• CSF liquid biopsy in patients with difusse glioma. Systematic review

  Sainz Vecino, Patricia Eliana (30-05-2023)

  Background: Diffuse gliomas are the most common primary tumors in the central nervous system, with a low survival rate. Tumor biopsy is the current method to demonstrate them, but it carries risks and does not always ...
• Use of ocrelizumab in patients with primary progressive multiple sclerosis

  Gibert Martí, Clàudia (30-05-2023)

  SUMMARY: Background: This study focuses on the treatment of Primary Progressive Multiple Sclerosis (PPMS), a subtype of MS characterized by a continuous deterioration of symptoms, affecting approximately 10-15% of MS ...
• Physical activity and oxidized LDL, does intensity matter?

  Benet Pozo, Roger (30-05-2023)

  ABSTRACT Objectives: The aim of this study was to determine the pattern of the dose-response relationship between leisure time physical activity practice, considering its intensity, and serum oxidized LDL levels. We ...

Ver todos los documentos